Physician profile
David Christopher Metzger
NPI 1568490464
$554,821.01
in general payments reported to CMS, 2019-2025
46 companies · $150K in 2025
The $150K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $96K · 2020: $36K · 2021: $60K · 2022: $52K · 2023: $94K · 2024: $67K · 2025: $150K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $228K · Food and Beverage: $68K · Travel and Lodging: $7,727 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,710 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $227,825.00 |
| Food and Beverage | $67,509.44 |
| Travel and Lodging | $7,726.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,710.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $187,660.96 | 2019-2025 | Supera, Emboshield Nav6, Esprit |
| Inspiremd Ltd | $183,752.18 | 2021-2025 | Cguard Prime Carotid Stent System, Cguard |
| Endologix LLC | $61,327.93 | 2019-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Amplitude Vascular Systems, INC. | $40,542.22 | 2024 | |
| Boston Scientific Corporation | $28,531.57 | 2019-2025 | General - Vascular Intervention, Eluvia, General - Therapies |
| Penumbra, INC. | $23,627.93 | 2020-2025 | Indigo System, Penumbra System |
| Medtronic, INC. | $15,587.47 | 2022-2025 | Mo.Ma Ultra, Endurant Iis |
| Shockwave Medical, INC | $5,620.96 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $1,388.63 | 2019-2023 | Diamondback Coronary |
| Surmodics, INC. | $1,381.37 | 2021-2025 | Pounce Thrombectomy System, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Abiomed | $934.18 | 2021-2023 | Impella |
| Contego Medical, INC | $735.45 | 2020-2025 | |
| Cordis US Corp. | $675.06 | 2024-2025 | Angioguard, Selution Slrpta |
| Edwards Lifesciences Corporation | $335.27 | 2019-2025 | Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $287.98 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $265.07 | 2020-2024 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm, Venovo |
| Cook Medical LLC | $240.60 | 2021-2025 | Zenith, Performer, Zilver Ptx |
| W. L. Gore & Associates, INC. | $204.50 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Novartis Pharmaceuticals Corporation | $173.59 | 2019-2023 | |
| Angiodynamics, INC. | $170.25 | 2022-2023 | Angiovac |
| Silk Road Medical, INC. | $148.24 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.55 | 2019-2022 | |
| Bolton Medical INC | $120.69 | 2021 | |
| Solventum Corporation | $115.73 | 2025 | V.A.C. Veraflo, Prevena, Activ.A.C. |
| E.R. Squibb & Sons, L.L.C. | $102.76 | 2019-2023 | Eliquis |
| Philips North America LLC | $101.86 | 2019-2025 | Elca |
| Cardiva Medical, INC. | $90.54 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.20 | 2019-2021 | |
| Stryker Corporation | $78.05 | 2025 | Flowtriever, Artix Mt |
| Pfizer INC. | $67.78 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $64.89 | 2020-2022 | |
| Medtronic Vascular, INC. | $59.35 | 2019 | |
| Siemens Medical Solutions USA, INC. | $55.15 | 2019 | |
| Atricure, INC. | $43.74 | 2023 | |
| Teleflex LLC | $33.51 | 2022 | |
| Ekos Corporation | $21.83 | 2019 | |
| Amgen INC. | $18.88 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $16.88 | 2019 | |
| Imperative Care, INC | $16.37 | 2024 | Symphony Catheter |
| Astrazeneca Pharmaceuticals Lp | $11.84 | 2021 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$346,792.30 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Metzger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.